Shilpa Medicare's Stock Sees -5.3% Decline, But Remains Strong in Long Term

Shilpa Medicare, a midcap pharmaceutical company, saw a decline of -5.3% in its stock price on May 3rd, 2024. This drop was in line with the overall performance of the sector, as the company underperformed by -4.38%. The stock had also fallen after two consecutive days of gains, indicating a possible trend reversal. On the same day, Shilpa Medicare's stock touched an intraday low of Rs 526.45, a decrease of -4.96%. However, the stock is still performing well in the long term, with its moving averages higher than the 20, 50, 100, and 200-day averages. The only exception is the 5-day moving average, which is currently lower. In comparison to the Sensex, Shilpa Medicare's stock performance was -5.28% on the day, while the Sensex only saw a decline of -0.84%. Over the past month, the company's stock has also outperformed the Sensex, with a 2.32% increase compared to the Sensex's 0.14% growth. While there has been no mention of investor interest or expert opinions, the stock has been given a 'Hold' call by MarketsMOJO. With a neutral and informative tone, it can be said that Shilpa Medicare's stock has seen a decline in its price, but it still remains a strong performer in the long term.